Recent FDA updates to its General Wellness and Clinical Decision Support (CDS) guidance signal a regulatory shift for digital health products, AI-enabled tools, and medical software. Related changes are also reshaping global life sciences and healthcare compliance in 2026.
A cross-industry outlook on the regulatory, technological, and market forces redefining business strategy in 2026 and beyond.
Leadership changes in Venezuela are causing heightened geopolitical risk and business uncertainty for US and multinational companies. Our cross-practice team is actively tracking developments and working with clients to assess risk, identify opportunities, and evaluate Venezuela-related operations.
- LawFlash: Venezuela Oil Sector Sanctions Update: Analyzing OFAC General License 46
- LawFlash: Compliance Landscape in Venezuela Following Nicolás Maduro’s Removal from Power
- LawFlash: Before Entering Venezuela, Companies Should Consider Indemnification from US Government
- Explore our Venezuela Global Capabilities
We are proud of our reputation in both the legal and the business communities. People know us for our uniquely collaborative work environment, for colleagues who truly care about one another, and for the powerful, innovative solutions we create for our clients.
We believe that Morgan Lewis is an exceptional place to work, and we are looking for exceptional people to join our team.